Does the media favor BTSG or LFST?

In the previous week, BrightSpring Health Services and BrightSpring Health Services both had 2 articles in the media. BrightSpring Health Services' average media sentiment score of 0.37 beat LifeStance Health Group's score of 0.32 indicating that BrightSpring Health Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BrightSpring Health Services 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral LifeStance Health Group 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor FMS or LFST?

In the previous week, Fresenius Medical Care AG & Co. KGaA and Fresenius Medical Care AG & Co. KGaA both had 2 articles in the media. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.97 beat LifeStance Health Group's score of 0.32 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fresenius Medical Care AG & Co. KGaA 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LifeStance Health Group 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer LFST or HIMS?

In the previous week, Hims & Hers Health had 16 more articles in the media than LifeStance Health Group. MarketBeat recorded 18 mentions for Hims & Hers Health and 2 mentions for LifeStance Health Group. Hims & Hers Health's average media sentiment score of 0.80 beat LifeStance Health Group's score of 0.32 indicating that Hims & Hers Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeStance Health Group 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Hims & Hers Health 8 Very Positive mention(s) 6 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to LFST or PACS?

In the previous week, PACS Group had 6 more articles in the media than LifeStance Health Group. MarketBeat recorded 8 mentions for PACS Group and 2 mentions for LifeStance Health Group. PACS Group's average media sentiment score of 0.44 beat LifeStance Health Group's score of 0.32 indicating that PACS Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeStance Health Group 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral PACS Group 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to CAI or LFST?

In the previous week, LifeStance Health Group had 1 more articles in the media than Caris Life Sciences. MarketBeat recorded 2 mentions for LifeStance Health Group and 1 mentions for Caris Life Sciences. Caris Life Sciences' average media sentiment score of 0.95 beat LifeStance Health Group's score of 0.32 indicating that Caris Life Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Caris Life Sciences 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LifeStance Health Group 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

LifeStance Health Group (LFST) Competitors

$9.84 +0.19 (+1.92%)

As of 12:02 PM Eastern

Compare

LFST vs. BTSG, FMS, HIMS, PACS, and CAI

Should you buy LifeStance Health Group stock or one of its competitors? MarketBeat compares LifeStance Health Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with LifeStance Health Group include BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), Hims & Hers Health (HIMS), PACS Group (PACS), and Caris Life Sciences (CAI). These companies are all part of the "healthcare" industry.

How does LifeStance Health Group compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and LifeStance Health Group (NASDAQ:LFST) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership, media sentiment and dividends.

BrightSpring Health Services has a beta of 1.87, indicating that its share price is 87% more volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.19, indicating that its share price is 19% more volatile than the broader market.

BrightSpring Health Services has higher revenue and earnings than LifeStance Health Group. BrightSpring Health Services is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$12.91B	1.05	$190.67M	$1.41	48.78
LifeStance Health Group	$1.42B	2.68	$9.66M	$0.06	163.92

BrightSpring Health Services presently has a consensus price target of $61.27, suggesting a potential downside of 10.93%. LifeStance Health Group has a consensus price target of $9.75, suggesting a potential downside of 0.86%. Given LifeStance Health Group's higher possible upside, analysts clearly believe LifeStance Health Group is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	16 Buy rating(s)	2 Strong Buy rating(s)	3.11
LifeStance Health Group	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.91

BrightSpring Health Services has a net margin of 2.27% compared to LifeStance Health Group's net margin of 1.55%. BrightSpring Health Services' return on equity of 14.63% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.27%	14.63%	4.41%
LifeStance Health Group	1.55%	1.56%	1.07%

In the previous week, BrightSpring Health Services and BrightSpring Health Services both had 2 articles in the media. BrightSpring Health Services' average media sentiment score of 0.37 beat LifeStance Health Group's score of 0.32 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrightSpring Health Services	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
LifeStance Health Group	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

85.5% of LifeStance Health Group shares are held by institutional investors. 2.8% of BrightSpring Health Services shares are held by company insiders. Comparatively, 3.2% of LifeStance Health Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

BrightSpring Health Services beats LifeStance Health Group on 10 of the 15 factors compared between the two stocks.

How does LifeStance Health Group compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and LifeStance Health Group (NASDAQ:LFST) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are held by institutional investors. 3.2% of LifeStance Health Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA has a beta of 0.8, indicating that its share price is 20% less volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.19, indicating that its share price is 19% more volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to LifeStance Health Group's net margin of 1.55%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%
LifeStance Health Group	1.55%	1.56%	1.07%

In the previous week, Fresenius Medical Care AG & Co. KGaA and Fresenius Medical Care AG & Co. KGaA both had 2 articles in the media. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.97 beat LifeStance Health Group's score of 0.32 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LifeStance Health Group	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Fresenius Medical Care AG & Co. KGaA currently has a consensus target price of $28.00, suggesting a potential upside of 20.44%. LifeStance Health Group has a consensus target price of $9.75, suggesting a potential downside of 0.86%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, equities analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.44
LifeStance Health Group	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.91

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than LifeStance Health Group. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.57	$1.11B	$1.90	12.24
LifeStance Health Group	$1.42B	2.68	$9.66M	$0.06	163.92

Summary

Fresenius Medical Care AG & Co. KGaA and LifeStance Health Group tied by winning 8 of the 16 factors compared between the two stocks.

How does LifeStance Health Group compare to Hims & Hers Health?

LifeStance Health Group (NASDAQ:LFST) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk.

LifeStance Health Group presently has a consensus price target of $9.75, suggesting a potential downside of 0.86%. Hims & Hers Health has a consensus price target of $29.37, suggesting a potential downside of 5.31%. Given LifeStance Health Group's stronger consensus rating and higher possible upside, analysts plainly believe LifeStance Health Group is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.91
Hims & Hers Health	2 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.13

LifeStance Health Group has a beta of 1.19, meaning that its share price is 19% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.37, meaning that its share price is 137% more volatile than the broader market.

LifeStance Health Group has a net margin of 1.55% compared to Hims & Hers Health's net margin of -0.56%. Hims & Hers Health's return on equity of 6.10% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	1.55%	1.56%	1.07%
Hims & Hers Health	-0.56%	6.10%	1.52%

In the previous week, Hims & Hers Health had 16 more articles in the media than LifeStance Health Group. MarketBeat recorded 18 mentions for Hims & Hers Health and 2 mentions for LifeStance Health Group. Hims & Hers Health's average media sentiment score of 0.80 beat LifeStance Health Group's score of 0.32 indicating that Hims & Hers Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeStance Health Group	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Hims & Hers Health	8 Very Positive mention(s)	6 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hims & Hers Health has higher revenue and earnings than LifeStance Health Group. Hims & Hers Health is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42B	2.68	$9.66M	$0.06	163.92
Hims & Hers Health	$2.35B	3.06	$128.37M	-$0.09	N/A

85.5% of LifeStance Health Group shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 3.2% of LifeStance Health Group shares are owned by insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Hims & Hers Health beats LifeStance Health Group on 9 of the 17 factors compared between the two stocks.

How does LifeStance Health Group compare to PACS Group?

LifeStance Health Group (NASDAQ:LFST) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, earnings, valuation, institutional ownership, analyst recommendations, dividends and risk.

85.5% of LifeStance Health Group shares are owned by institutional investors. 3.2% of LifeStance Health Group shares are owned by company insiders. Comparatively, 70.1% of PACS Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

PACS Group has higher revenue and earnings than LifeStance Health Group. PACS Group is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42B	2.68	$9.66M	$0.06	163.92
PACS Group	$5.29B	1.21	$191.54M	$1.56	25.90

PACS Group has a net margin of 4.49% compared to LifeStance Health Group's net margin of 1.55%. PACS Group's return on equity of 26.47% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	1.55%	1.56%	1.07%
PACS Group	4.49%	26.47%	4.36%

In the previous week, PACS Group had 6 more articles in the media than LifeStance Health Group. MarketBeat recorded 8 mentions for PACS Group and 2 mentions for LifeStance Health Group. PACS Group's average media sentiment score of 0.44 beat LifeStance Health Group's score of 0.32 indicating that PACS Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeStance Health Group	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
PACS Group	2 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

LifeStance Health Group currently has a consensus target price of $9.75, suggesting a potential downside of 0.86%. PACS Group has a consensus target price of $48.00, suggesting a potential upside of 18.79%. Given PACS Group's higher probable upside, analysts clearly believe PACS Group is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.91
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

Summary

PACS Group beats LifeStance Health Group on 10 of the 16 factors compared between the two stocks.

How does LifeStance Health Group compare to Caris Life Sciences?

Caris Life Sciences (NASDAQ:CAI) and LifeStance Health Group (NASDAQ:LFST) are both mid-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations, media sentiment and dividends.

Caris Life Sciences has a net margin of 3.75% compared to LifeStance Health Group's net margin of 1.55%. Caris Life Sciences' return on equity of 98.28% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Caris Life Sciences	3.75%	98.28%	48.87%
LifeStance Health Group	1.55%	1.56%	1.07%

In the previous week, LifeStance Health Group had 1 more articles in the media than Caris Life Sciences. MarketBeat recorded 2 mentions for LifeStance Health Group and 1 mentions for Caris Life Sciences. Caris Life Sciences' average media sentiment score of 0.95 beat LifeStance Health Group's score of 0.32 indicating that Caris Life Sciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Caris Life Sciences	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LifeStance Health Group	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

LifeStance Health Group has higher revenue and earnings than Caris Life Sciences. Caris Life Sciences is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Caris Life Sciences	$812.03M	6.68	-$68.09M	-$7.61	N/A
LifeStance Health Group	$1.42B	2.68	$9.66M	$0.06	163.92

Caris Life Sciences presently has a consensus price target of $27.56, suggesting a potential upside of 43.66%. LifeStance Health Group has a consensus price target of $9.75, suggesting a potential downside of 0.86%. Given Caris Life Sciences' higher probable upside, equities research analysts clearly believe Caris Life Sciences is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45
LifeStance Health Group	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.91

85.5% of LifeStance Health Group shares are held by institutional investors. 50.0% of Caris Life Sciences shares are held by company insiders. Comparatively, 3.2% of LifeStance Health Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

LifeStance Health Group beats Caris Life Sciences on 8 of the 15 factors compared between the two stocks.

Get LifeStance Health Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LFST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LFST vs. The Competition

Export

Metric	LifeStance Health Group	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$3.82B	$5.92B	$6.69B	$12.21B
Dividend Yield	N/A	1.54%	2.68%	5.89%
P/E Ratio	164.08	37.85	25.35	24.07
Price / Sales	2.68	26.39	582.60	125.42
Price / Cash	56.12	17.26	45.29	53.76
Price / Book	2.52	3.43	10.73	6.38
Net Income	$9.66M	$218.81M	$3.56B	$336.99M
7 Day Performance	9.52%	5.11%	1.31%	-0.85%
1 Month Performance	33.09%	6.55%	1.09%	0.73%
1 Year Performance	98.69%	23.00%	31.44%	29.29%

LifeStance Health Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LFST LifeStance Health Group	3.3419 of 5 stars	$9.84 +1.9%	$9.75 -0.9%	+90.0%	$3.82B	$1.42B	164.08	10,961	News Coverage
BTSG BrightSpring Health Services	3.9171 of 5 stars	$66.84 -0.5%	$61.27 -8.3%	+194.9%	$13.19B	$12.91B	47.40	23,500	Analyst Forecast
FMS Fresenius Medical Care AG & Co. KGaA	4.5209 of 5 stars	$23.73 +1.5%	$28.00 +18.0%	-14.2%	$12.82B	$19.36B	12.49	1,488	Gap Down
HIMS Hims & Hers Health	3.1369 of 5 stars	$33.00 -1.6%	$29.37 -11.0%	-24.1%	$7.64B	$2.35B	N/A	2,442	Insider Trade Gap Down
PACS PACS Group	4.0411 of 5 stars	$37.29 -1.3%	$48.00 +28.7%	+205.5%	$5.90B	$5.43B	23.90	47,455	Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LFST) was last updated on 6/25/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

LifeStance Health Group (LFST) Competitors

LFST vs. BTSG, FMS, HIMS, PACS, and CAI

How does LifeStance Health Group compare to BrightSpring Health Services?

Summary

How does LifeStance Health Group compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does LifeStance Health Group compare to Hims & Hers Health?

Summary

How does LifeStance Health Group compare to PACS Group?

Summary

How does LifeStance Health Group compare to Caris Life Sciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFST vs. The Competition

LifeStance Health Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

LifeStance Health Group (LFST) Competitors

LFST vs. BTSG, FMS, HIMS, PACS, and CAI

How does LifeStance Health Group compare to BrightSpring Health Services?

Which has more risk & volatility, BTSG or LFST?

Which has preferable valuation and earnings, BTSG or LFST?

Do analysts recommend BTSG or LFST?

Is BTSG or LFST more profitable?

Does the media favor BTSG or LFST?

Do institutionals & insiders hold more shares of BTSG or LFST?

Summary

How does LifeStance Health Group compare to Fresenius Medical Care AG & Co. KGaA?

Do institutionals and insiders hold more shares of FMS or LFST?

Which has more risk and volatility, FMS or LFST?

Is FMS or LFST more profitable?

Does the media favor FMS or LFST?

Do analysts prefer FMS or LFST?

Which has stronger earnings & valuation, FMS or LFST?

Summary

How does LifeStance Health Group compare to Hims & Hers Health?

Do analysts prefer LFST or HIMS?

Which has more volatility and risk, LFST or HIMS?

Is LFST or HIMS more profitable?

Does the media prefer LFST or HIMS?

Which has preferable earnings and valuation, LFST or HIMS?

Do insiders and institutionals hold more shares of LFST or HIMS?

Summary

How does LifeStance Health Group compare to PACS Group?

Do insiders & institutionals hold more shares of LFST or PACS?

Which has stronger valuation and earnings, LFST or PACS?

Is LFST or PACS more profitable?

Does the media refer more to LFST or PACS?

Do analysts prefer LFST or PACS?

Summary

How does LifeStance Health Group compare to Caris Life Sciences?

Is CAI or LFST more profitable?

Does the media refer more to CAI or LFST?

Which has higher valuation and earnings, CAI or LFST?

Do analysts rate CAI or LFST?

Do institutionals and insiders believe in CAI or LFST?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFST vs. The Competition

LifeStance Health Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools